Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Trajan Group Holdings Ltd ( (AU:TRJ) ) is now available.
Trajan Group Holdings Limited held its 2025 Annual General Meeting, where all resolutions presented to shareholders were carried with significant majorities. The resolutions included the adoption of the remuneration report and the granting of options to directors, reflecting strong shareholder support for the company’s strategic direction and governance. This outcome reinforces Trajan’s stable position in the analytical science industry and indicates continued confidence from its stakeholders.
The most recent analyst rating on (AU:TRJ) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
More about Trajan Group Holdings Ltd
Trajan Group Holdings Limited is a global developer and manufacturer of analytical and life sciences products and devices. The company focuses on enabling science that benefits personal health through scientific tools and solutions, with applications in the analysis of biological, food, and environmental samples. Trajan is committed to advancing decentralised, personalised, data-based healthcare and operates with over 600 employees across manufacturing sites in the US, Australia, Europe, and Malaysia.
Average Trading Volume: 21,780
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$122M
See more data about TRJ stock on TipRanks’ Stock Analysis page.